Precision BioSciences, Inc. Profile Avatar - Palmy Investing

Precision BioSciences, Inc.

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides…

Biotechnology
US, Durham [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Precision BioSciences, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Precision BioSciences, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Precision BioSciences, Inc..

End of DTIL's Analysis
CIK: 1357874 CUSIP: 74019P108 ISIN: US74019P2074 LEI: - UEI: -
Secondary Listings
DTIL has no secondary listings inside our databases.